CLU and lung adenocarcinoma: In conclusion, our data suggested that the higher levels of CLSTN1, CLU and NGAL in lung adenocarcinoma cultured medium as well as in serum samples tended to be tumor biomarkers for lung adenocarcinoma diagnosis.